Furthermore, in primary human melanoma samples, an elevated expression of the GH-releasing hormone receptor (GHRH) (GHRHR) has been demonstrated [25], while GHRH analogues have been shown to suppress the growth of malignant melanomas in vivo [26]. This evidence concerns the gene GHRH and melanoma.